ArticleScientific reports2023
Future world cancer death rate prediction.
Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
31 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Trends and developments in health systems modeling: a bibliometric analysis.Frontiers in digital health · 2025Pooled it
- Landscape and evolutionary trends of nanotechnology in cancer radiosensitization.Discover nano · 2026Review
- Platinum-based functional nanomaterials: mechanisms and therapeutic strategies in cancer radiotherapy sensitization.Molecular cancer · 2026Review
- In silico-driven identification of potent CDK9 inhibitors through bioisosteric replacement and multi-stage virtual screening.Scientific reports · 2025Article
- Role of Nanobubble Cavitation in Triggering Drug Release from Boron-Nitride and Carbon Nanocapsules and Their Diffusion for Drug Delivery Applications: A Molecular Dynamics Study.International journal of molecular sciences · 2025Article
- Biologically Active Benzimidazole Hybrids as Cancer Therapeutics: Recent Advances.Pharmaceuticals (Basel, Switzerland) · 2025Review
- Viscoelastic characterization of the human osteosarcoma cancer cell line MG-63 using a fractional-order zener model through automated algorithm design and configuration.Scientific reports · 2025Article
- Correlations of resilience with coping styles and quality of life in patients with malignancies.World journal of psychiatry · 2025Article
- Phytosome-Enhanced Secondary Metabolites for Improved Anticancer Efficacy: Mechanisms and Bioavailability Review.Drug design, development and therapy · 2025Review
- Design, synthesis,Frontiers in chemistry · 2025Article
- SilverPharmaceuticals (Basel, Switzerland) · 2024Review
- Evaluating the Anticancer Properties of Novel Piscidinol A Derivatives: Insights from DFT, Molecular Docking, and Molecular Dynamics Studies.ACS omega · 2024Article
- Review
- HIV deathrate prediction by Gaidai multivariate risks assessment method.Immunity, inflammation and disease · 2024Article
- Design, Synthesis, and Anticancer Activity of Novel Enmein-Type Diterpenoid Derivatives Targeting the PI3K/Akt/mTOR Signaling Pathway.Molecules (Basel, Switzerland) · 2024Article
- Future worldwide coronavirus disease 2019 epidemic predictions by Gaidai multivariate risk evaluation method.Analytical science advances · 2024Article
- Virtual screening of FOXO3a activators from natural product-like compound library.Molecular diversity · 2024Article
- Exploring the Potential Role of Phytopharmaceuticals in Alleviating Toxicities of Chemotherapeutic Agents.Current protein & peptide science · 2024Review
- Antitumoral melatonin-loaded nanostructured lipid carriers.Nanomedicine (London, England) · 2024Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cancer is a worldwide illness that causes significant morbidity and death and imposes an immense cost on global public health. Modelling such a phenomenon is complex because of the non-stationarity and complexity of cancer waves. Apply modern novel statistical methods directly to raw clinical data. To estimate extreme cancer death rate likelihood at any period in any location of interest. Traditional statistical methodologies that deal with temporal observations of multi-regional processes cannot adequately deal with substantial regional dimensionality and cross-correlation of various regional variables. Setting: multicenter, population-based, medical survey data-based biostatistical approach. Due to the non-stationarity and complicated nature of cancer, it is challenging to model such a phenomenon. This paper offers a unique bio-system dependability technique suited for multi-regional environmental and health systems. When monitored over a significant period, it yields a reliable long-term projection of the chance of an exceptional cancer mortality rate. Traditional statistical approaches dealing with temporal observations of multi-regional processes cannot effectively deal with large regional dimensionality and cross-correlation between multiple regional data. The provided approach may be employed in numerous public health applications, depending on their clinical survey data.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.